Trade Humana - HUM CFD

Market is not available at the momentMarket information is presented
as of 2026-10-16T19:48:44+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread1.26
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02224 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02224%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00001 %
($0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00001%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close431.07
Open422.85
1-Year Change61.41%
Day's Range411.85 - 424.91

Trade Humana - HUM

About Humana Inc

Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Humana Inc revenues increased 8% to $83.06B. Net income decreased 13% to $2.93B. Revenues reflect Retail segment increase of 10% to $73.84B, Healthcare Services segment increase from $1.02B to $2.22B, Medical Expense Ratio -%-Employer Group decrease of 4% to 82.5%. Net income was offset by Eliminations/Corporate segment loss totaling $202M vs. income of $1.24B.

Equity composition

Common Stock $.16 2/3 Par, 3/11, 300M auth., 191,607,107 issd., less 23,212,730 shs. in Treas. @ $583.3M. Insiders owns approx. 0.57%. PO11/82, 3M shares @ $13.125 by Lehman Brothers Kuhn Loeb. *NOTE: 3/93, the acute care hospital division (Galen Health Care) was spun off. FY'99-'00 and FY'00-'01 Q's are reclassified.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready